By IANS,
Mumbai : The share price of India’s leading drugmaker Ranbaxy Laboratories fell by nearly eight percent following the settlement with Pfizer on a patent dispute.
The stock ended down 7.68 percent at the Bombay Stock Exchange at Rs.598.20 after touching a low of Rs.548.10 and a high of Rs.613.70.
On Wednesday, Pfizer said Ranbaxy can start selling a US generic form of its cholesterol drug Lipitor by late 2011.